查看購物車
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
2088965

心臟假體市場：2026-2032年全球市場預測（依產品類型、手術類型、材料類型、適應症、最終用戶和通路分類）

Cardiac Prosthetic Devices Market by Product Type, Procedure Type, Material Type, Indication, End User, Distribution Channel - Global Forecast 2026-2032
出版日期: | 出版商: 360iResearch | 英文 187 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計到 2032 年，心臟假體市場將成長至 332.4 億美元，複合年成長率為 16.26%。

主要市場統計數據
基準年 2025 115.7億美元
預計年份：2026年 134.2億美元
預測年份 2032 332.4億美元
複合年成長率 (%) 16.26%

心臟人工器官市場概覽

心臟假體在現代結構性心臟疾病和進行性心臟衰竭的治療中發揮核心作用，涵蓋機械心臟瓣膜、生物瓣膜、經導管主動脈瓣置換術裝置、環狀成形術環、封堵裝置、移植物和循環支持技術。這種需求源自於全球心血管疾病的沉重負擔，世界衛生組織（WHO）已將其列為全球首要死因，同時，人口老化也增加了患有主動脈瓣狹窄、二尖瓣逆流、心臟衰竭和其他需要器械介入治療的疾病的風險。

心臟假體裝置領域的變革性變化

心臟假體器械的市場格局正從開胸手術轉向導管介入和混合手術。經導管主動脈瓣置換術術（TAVR）在臨床證據、真實世界註冊研究和指南採納的支持下，在許多監管市場中適應症不斷擴大，從高風險患者擴展到更廣泛的風險族群。這種轉變擴大了老年和體弱患者的治療選擇範圍，同時也加劇了瓣膜耐久性、輸送系統特性、影像相容性和術後效果等方面的競爭。

人工智慧（AI）的累積影響

人工智慧 (AI) 正逐漸成為心臟人工瓣膜整個價值鏈中累積的驅動力。在術前規劃中，AI 驅動的心臟超音波圖、CT 分析和 3D 分割技術能夠輔助臨床醫生評估瓣環尺寸、鈣化模式、血管通路以及人工瓣膜尺寸的選擇。這些功能在經導管瓣膜置換術、瓣週漏風險評估以及複雜結構性心臟疾病患者的選擇中尤其重要。

主要區域洞察

北美地區憑藉其龐大的心血管手術量、先進的醫院基礎設施、完善的保險報銷體係以及對治療結構性心臟疾病創新技術的早期應用，仍然是心臟假體和器械的主要市場。美國透過獲得FDA批准的經導管瓣膜技術、強大的臨床試驗網路以及廣泛應用真實世界註冊研究，推動了該地區的發展。另一方面，加拿大則憑藉其全民健保體系、集中採購流程以及對微創瓣膜治療日益成長的需求，為該地區的發展做出了貢獻。

關鍵群體特定見解

隨著新加坡、泰國、馬來西亞、印尼、越南和菲律賓不斷完善其心血管醫療保健體系，東協地區在心臟假體器材市場的地位日益重要。新加坡是區域內專門治療結構性心臟病、開展臨床培訓和推廣醫療技術的中心，而隨著保險覆蓋範圍的擴大、醫院投資的增加以及專家的穩定，預計整個東協市場的治療量將長期成長。

主要國家的概況

美國是許多心臟假體製造商最大的單一市場，這得益於其先進的結構性心臟疾病治療計畫、FDA監管路徑、聯邦醫療保險福利體係以及較高的手術普及率。加拿大憑藉公共醫療體系提供穩定的需求，而墨西哥則面臨私立醫院數量不斷成長以及公共醫療服務取得困難的雙重挑戰。巴西是拉丁美洲最重要的市場，擁有龐大的病患群體和成熟的心臟外科手術技術，但健保報銷機制的不完善和進口成本高昂正在影響其產品普及。

為行業領導者提供的實用建議

產業領導者應優先考慮差異化的臨床證據，而不僅僅是設備的功能。他們必須透過隨機試驗、上市後註冊研究和真實世界數據來證明產品的耐用性、血液動力學性能、低併發症率和經濟價值。能夠將臨床結果與醫院工作流程效益連結起來的公司，在以價值為導向的採購環境中將更具優勢。

調查方法

本執行摘要基於結構化的調查方法，該方法結合了二手資料研究、一手市場檢驗和分析三角驗證。二級資訊來源包括監管資料庫、公共衛生資訊來源、臨床指南、同行評審文獻、專利趨勢、醫院採購趨勢以及醫療設備不利事件報告系統。本摘要特別強調世界衛生組織 (WHO)、國家監管機構、心臟病學專業協會和經認證的臨床試驗註冊機構的證據。

結論

心臟假體市場正步入一個更實證和技術主導的階段。人口老化、心血管疾病盛行率上升、經導管介入治療的創新、先進生物材料以及人工智慧驅動的治療計劃，都在重塑我們治療瓣膜性心臟病及相關結構性心臟疾病的方式。市場需求不再只取決於手術置換術的數量，而是越來越受到微創治療、生命週期療效和整合式照護路徑的影響。

目錄

第1章：序言

第2章：調查方法

  • 調查設計
  • 研究框架
  • 市場規模預測
  • 數據三角測量
  • 調查結果
  • 調查的前提
  • 研究限制

第3章執行摘要

  • 首席主管觀點
  • 市場規模和成長趨勢
  • 2025年市佔率分析
  • FPNV定位矩陣，2025
  • 新的商機
  • 下一代經營模式
  • 產業藍圖

第4章 市場概覽

  • 產業生態系與價值鏈分析
  • 市場動態
  • 波特五力分析
  • PESTLE分析
  • 市場展望
  • 上市策略

第5章 市場洞察

  • 消費者洞察與終端用戶觀點
  • 消費者體驗基準
  • 機會映射
  • 分銷通路分析
  • 價格趨勢分析
  • 監理合規和標準框架
  • ESG與永續性分析
  • 中斷和風險情景
  • 投資報酬率和成本效益分析

第6章：人工智慧的累積影響，2026年

第7章 心臟人工器官市場：依產品類型分類

  • 心臟瓣膜
  • 左心室輔助裝置
    • 耐用型心室輔助裝置
    • 暫時性心室輔助裝置
  • 心律調節器
    • 植入式心臟節律器
      • 單腔心律調節器
      • 雙腔心律調節器
      • 三腔心律調節器
    • 體外心律調節器
  • 植入式心臟整流去顫器
  • 心室輔助裝置

第8章：心臟假體市場：依手術類型分類

  • 外科手術
    • 開胸手術
    • 微創手術
  • 經導管手術
    • 經導管主動脈瓣置換術
    • 經導管二尖瓣置換術

第9章：心臟人工器官市場：依材料類型分類

  • 生物材料
    • 牛組織
    • 豬源性組織
  • 合成材料
    • 聚合物
    • 熱解碳
    • 金屬

第10章：心臟假體市場：依適應症分類

  • 心臟瓣膜疾病
    • 主動脈瓣狹窄
    • 二尖瓣逆流
    • 肺瓣膜疾病
  • 心律不整
    • 心搏過緩
    • 心搏過速
    • 心房顫動
  • 心臟衰竭
  • 心肌病

第11章 心臟人工器官市場：依最終用戶分類

  • 門診手術中心
  • 心臟中心
  • 醫院

第12章：心臟人工器官市場：依分銷管道分類

  • 線上
  • 離線

第13章：心臟假體市場：依地區分類

  • 亞太地區
  • 北美洲
  • 拉丁美洲
  • 歐洲
  • 中東
  • 非洲

第14章 心臟人工器官市場：依組別分類

  • ASEAN
  • GCC
  • EU
  • BRICS
  • G7
  • NATO

第15章 心臟人工器官市場：依國家分類

  • 美國
  • 加拿大
  • 墨西哥
  • 巴西
  • 英國
  • 德國
  • 法國
  • 俄羅斯
  • 義大利
  • 西班牙
  • 中國
  • 印度
  • 日本
  • 澳洲
  • 韓國

第16章 競爭格局

  • 市場集中度分析，2025年
    • 濃度比（CR）
    • 赫芬達爾-赫希曼指數 (HHI)
  • 近期趨勢及影響分析，2025 年
  • 2025年產品系列分析
  • 基準分析，2025 年

第17章：公司簡介

  • 4C Medical Technologies, Inc.
  • Abbott Laboratories
  • Artivion, Inc.
  • AtriCure, Inc.
  • Berlin Heart GmbH
  • BIOTRONIK SE & Co. KG
  • Boston Scientific Corporation
  • Braile Biomedica
  • Colibri Heart Valve, LLC
  • Corcym Srl
  • Edwards Lifesciences Corporation
  • Getinge AB
  • JenaValve Technology, Inc.
  • Labcor Laboratorios Ltda.
  • Lepu Medical Technology（Beijing）Co., Ltd.
  • LivaNova PLC
  • Medtronic plc
  • Meril Life Sciences Pvt. Ltd.
  • MicroPort Scientific Corporation
  • Shree Pacetronix Ltd.
  • SynCardia Systems, LLC
  • Terumo Corporation
  • TTK Healthcare Ltd.
  • Venus Medtech（Hangzhou）Inc.
  • WL Gore & Associates, Inc.
Product Code: MRR-ED54C46E8699

The Cardiac Prosthetic Devices Market is projected to grow by USD 33.24 billion at a CAGR of 16.26% by 2032.

KEY MARKET STATISTICS
Base Year [2025] USD 11.57 billion
Estimated Year [2026] USD 13.42 billion
Forecast Year [2032] USD 33.24 billion
CAGR (%) 16.26%

Cardiac Prosthetic Devices Market Overview

Cardiac prosthetic devices are central to modern structural heart and advanced heart failure care, spanning mechanical heart valves, bioprosthetic valves, transcatheter aortic valve replacement devices, annuloplasty rings, occluders, grafts, and circulatory support technologies. Demand is anchored by the global burden of cardiovascular disease, which the World Health Organization identifies as the leading cause of death worldwide, and by aging populations that are more likely to develop aortic stenosis, mitral regurgitation, heart failure, and other conditions requiring device-based intervention.

The market is increasingly shaped by minimally invasive cardiac surgery, transcatheter valve therapies, improved biomaterials, and stronger evidence from registries and randomized clinical trials. Hospitals, cardiac centers, and ambulatory specialty programs are prioritizing devices that reduce procedural risk, shorten length of stay, and support durable outcomes. For manufacturers and investors, the strongest opportunities sit at the intersection of clinical efficacy, reimbursement access, regulatory compliance, supply chain resilience, and surgeon or interventional cardiologist adoption.

Transformative Shifts in the Cardiac Prosthetic Devices Landscape

The cardiac prosthetic devices landscape is shifting from open surgical replacement toward catheter-based and hybrid procedures. Transcatheter aortic valve replacement has moved from high-risk patients into broader risk categories in many regulated markets, supported by clinical evidence, real-world registries, and guideline adoption. This transition is expanding treatment eligibility for elderly and frail patients while intensifying competition around valve durability, delivery system profile, imaging compatibility, and post-procedure outcomes.

Materials innovation is also transforming the sector. Anti-calcification tissue treatment, polymer valves, refined pyrolytic carbon components, and advanced coatings are being developed to improve durability, hemocompatibility, and resistance to thrombosis or structural valve deterioration. At the same time, value-based procurement is pushing companies to demonstrate not only device performance but also total cost-of-care benefits, including fewer readmissions, lower complication rates, and predictable procedural workflows.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is becoming a cumulative enabler across the cardiac prosthetic devices value chain. In pre-procedure planning, AI-assisted echocardiography, CT analysis, and 3D segmentation help clinicians evaluate annular dimensions, calcification patterns, vascular access, and prosthesis sizing. These capabilities are particularly relevant for transcatheter valve replacement, paravalvular leak risk assessment, and patient selection in complex structural heart disease.

AI is also improving manufacturing quality, post-market surveillance, and clinical workflow. Machine learning models can support defect detection, predictive maintenance in production environments, real-world evidence analysis, and early identification of adverse event signals. The most commercially relevant AI applications are those integrated into regulated clinical pathways, validated with diverse datasets, and aligned with data privacy requirements such as HIPAA in the United States and GDPR in Europe.

Key Regional Insights

North America remains a leading region for cardiac prosthetic devices because of high cardiovascular procedure volumes, advanced hospital infrastructure, established reimbursement pathways, and early adoption of structural heart innovations. The United States drives much of the regional momentum through FDA-reviewed transcatheter heart valve technologies, strong clinical trial networks, and extensive use of real-world registries, while Canada contributes through universal health coverage, centralized purchasing processes, and growing demand for minimally invasive valve interventions.

Europe continues to be a major market supported by experienced cardiac surgery programs, strong guideline-based care, and adoption of transcatheter valve therapies across Germany, France, Italy, Spain, and the United Kingdom. The European Union Medical Device Regulation has increased the evidence and compliance burden for manufacturers, but it has also elevated the importance of clinical documentation, post-market clinical follow-up, and device traceability. Asia-Pacific is expanding as China, India, Japan, South Korea, Australia, and ASEAN healthcare systems invest in structural heart programs, domestic manufacturing, and broader access to specialist cardiac care.

Latin America, the Middle East, and Africa present mixed but important growth pathways. Brazil and Mexico are key Latin American markets, with demand tied to public-private hospital capacity and import-dependent device access. GCC countries in the Middle East are investing in tertiary cardiac centers and medical technology procurement, while broader African adoption is constrained by affordability, limited specialist infrastructure, and uneven access to cardiac surgery. Across these regions, growth depends on reimbursement design, physician training, local distribution strength, and partnerships that expand access without compromising quality.

Key Group Insights

ASEAN is becoming more relevant for cardiac prosthetic devices as Singapore, Thailand, Malaysia, Indonesia, Vietnam, and the Philippines expand cardiovascular care capacity. Singapore functions as a regional hub for specialized structural heart procedures, clinical training, and medical technology commercialization, while larger ASEAN markets offer long-term procedural potential as insurance coverage, hospital investment, and specialist availability improve.

The GCC is characterized by high healthcare spending per capita, modernization of tertiary hospitals, and a strong preference for advanced imported medical devices. Saudi Arabia, the United Arab Emirates, Qatar, and other GCC markets are prioritizing cardiovascular centers of excellence, which supports adoption of transcatheter valves, surgical prosthetic valves, and advanced heart failure technologies. In the European Union, regulatory harmonization under MDR creates a structured but demanding environment, rewarding manufacturers with robust clinical evidence, quality systems, and post-market surveillance capabilities.

BRICS economies offer scale and strategic manufacturing opportunities, especially in China, India, and Brazil, where cardiovascular disease burden is high and local production policies influence procurement. G7 markets remain innovation leaders because of mature reimbursement, clinical research depth, and early uptake of premium technologies. NATO countries overlap significantly with high-income North American and European markets, where supply chain security, cybersecurity for connected systems, and resilient access to critical medical devices have become more prominent policy priorities.

Key Country Insights

The United States is the largest single-country opportunity for many cardiac prosthetic device manufacturers due to advanced structural heart programs, FDA regulatory pathways, Medicare coverage mechanisms, and high procedural adoption. Canada offers stable demand through publicly funded care, while Mexico combines private hospital growth with public sector access challenges. Brazil is Latin America's most significant market, supported by large patient volumes and established cardiac surgery expertise, though reimbursement variability and import costs influence adoption.

In Europe, the United Kingdom, Germany, France, Italy, and Spain each maintain strong cardiac care ecosystems, but purchasing dynamics differ by national health system, tendering models, and hospital budgets. Germany is notable for procedural capacity and specialized centers, France and the United Kingdom emphasize health technology assessment and evidence-based reimbursement, and Italy and Spain show continued demand for both surgical and transcatheter solutions. Russia has domestic capacity and cardiovascular demand, but market access can be affected by sanctions, procurement restrictions, currency volatility, and localization policies.

China is scaling structural heart care through hospital investment, regulatory reform, and domestic device innovation, while India offers substantial long-term demand driven by population size, rising diagnosis, and expanding private cardiac networks. Japan is a high-value market with rigorous regulatory expectations, advanced clinical adoption, and a large aging population. Australia supports premium technology uptake through specialized centers and reimbursement systems, and South Korea combines strong hospital infrastructure, medical technology innovation, and growing use of minimally invasive cardiac procedures.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize differentiated clinical evidence, not only device features. Randomized trials, post-market registries, and real-world evidence should demonstrate durability, hemodynamic performance, lower complication rates, and economic value. Companies that connect clinical outcomes with hospital workflow benefits will be better positioned in value-based procurement environments.

Manufacturers should also invest in physician training, imaging integration, AI-enabled planning tools, and region-specific access models. In high-income markets, success depends on premium innovation, regulatory excellence, and lifecycle management. In emerging markets, companies should align pricing, financing, distribution, and local partnerships with public health priorities. Supply chain resilience, cybersecurity, quality transparency, and proactive regulatory surveillance should be treated as board-level priorities.

Research Methodology

This executive summary is developed using a structured research methodology that combines secondary research, primary market validation, and analytical triangulation. Secondary inputs include regulatory databases, public health sources, clinical guidelines, peer-reviewed literature, patent activity, hospital procurement trends, and medical device adverse event reporting systems. Particular attention is given to evidence from organizations such as the World Health Organization, national regulators, professional cardiology societies, and recognized clinical trial registries.

Primary validation focuses on perspectives from manufacturers, distributors, clinicians, hospital procurement teams, reimbursement specialists, and regional market experts. Findings are assessed through triangulation across clinical adoption, regulatory status, reimbursement environment, installed care infrastructure, and competitive positioning. This approach supports an evidence-based view of demand drivers, barriers, regional differences, and strategic opportunities in cardiac prosthetic devices.

Conclusion

The cardiac prosthetic devices market is entering a more evidence-intensive and technology-driven phase. Aging populations, cardiovascular disease prevalence, transcatheter innovation, advanced biomaterials, and AI-enabled planning are collectively reshaping how cardiac valve disease and related structural heart conditions are treated. Demand is no longer defined only by surgical replacement volumes; it is increasingly shaped by minimally invasive access, lifecycle outcomes, and integrated care pathways.

Future leadership will depend on the ability to combine durable device performance with regulatory discipline, real-world evidence, affordability, and regional execution. Companies that address unmet clinical needs while supporting physicians, payers, and hospitals with measurable value are best positioned to capture sustainable growth in the global cardiac prosthetic devices industry.

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Definition
  • 1.3. Market Segmentation & Coverage
  • 1.4. Years Considered for the Study
  • 1.5. Currency Considered for the Study
  • 1.6. Language Considered for the Study
  • 1.7. Key Stakeholders

2. Research Methodology

  • 2.1. Introduction
  • 2.2. Research Design
    • 2.2.1. Primary Research
    • 2.2.2. Secondary Research
  • 2.3. Research Framework
    • 2.3.1. Qualitative Analysis
    • 2.3.2. Quantitative Analysis
  • 2.4. Market Size Estimation
    • 2.4.1. Top-Down Approach
    • 2.4.2. Bottom-Up Approach
  • 2.5. Data Triangulation
  • 2.6. Research Outcomes
  • 2.7. Research Assumptions
  • 2.8. Research Limitations

3. Executive Summary

  • 3.1. Introduction
  • 3.2. CXO Perspective
  • 3.3. Market Size & Growth Trends
  • 3.4. Market Share Analysis, 2025
  • 3.5. FPNV Positioning Matrix, 2025
  • 3.6. New Revenue Opportunities
  • 3.7. Next-Generation Business Models
  • 3.8. Industry Roadmap

4. Market Overview

  • 4.1. Introduction
  • 4.2. Industry Ecosystem & Value Chain Analysis
    • 4.2.1. Supply-Side Analysis
    • 4.2.2. Demand-Side Analysis
    • 4.2.3. Stakeholder Analysis
  • 4.3. Market Dynamics
    • 4.3.1. Key Drivers
    • 4.3.2. Key Restraints
    • 4.3.3. Key Opportunities
    • 4.3.4. Key Challenges
  • 4.4. Porter's Five Forces Analysis
  • 4.5. PESTLE Analysis
  • 4.6. Market Outlook
    • 4.6.1. Near-Term Market Outlook (0-2 Years)
    • 4.6.2. Medium-Term Market Outlook (3-5 Years)
    • 4.6.3. Long-Term Market Outlook (5-10 Years)
  • 4.7. Go-to-Market Strategy

5. Market Insights

  • 5.1. Consumer Insights & End-User Perspective
  • 5.2. Consumer Experience Benchmarking
  • 5.3. Opportunity Mapping
  • 5.4. Distribution Channel Analysis
  • 5.5. Pricing Trend Analysis
  • 5.6. Regulatory Compliance & Standards Framework
  • 5.7. ESG & Sustainability Analysis
  • 5.8. Disruption & Risk Scenarios
  • 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of Artificial Intelligence 2026

7. Cardiac Prosthetic Devices Market, by Product Type

  • 7.1. Heart Valves
  • 7.2. Left Ventricular Assist Devices
    • 7.2.1. Durable Ventricular Assist Devices
    • 7.2.2. Temporary Ventricular Assist Devices
  • 7.3. Pacemakers
    • 7.3.1. Implantable Pacemakers
      • 7.3.1.1. Single Chamber Pacemakers
      • 7.3.1.2. Dual Chamber Pacemakers
      • 7.3.1.3. Triple Chamber Pacemakers
    • 7.3.2. External Pacemakers
  • 7.4. Implantable Cardioverter Defibrillators
  • 7.5. Ventricular Assist Devices

8. Cardiac Prosthetic Devices Market, by Procedure Type

  • 8.1. Surgical Procedures
    • 8.1.1. Open Heart Surgery
    • 8.1.2. Minimally Invasive Surgery
  • 8.2. Transcatheter Procedures
    • 8.2.1. Transcatheter Aortic Valve Replacement
    • 8.2.2. Transcatheter Mitral Valve Replacement

9. Cardiac Prosthetic Devices Market, by Material Type

  • 9.1. Biological Materials
    • 9.1.1. Bovine Tissue
    • 9.1.2. Porcine Tissue
  • 9.2. Synthetic Materials
    • 9.2.1. Polymers
    • 9.2.2. Pyrolytic Carbon
    • 9.2.3. Metals

10. Cardiac Prosthetic Devices Market, by Indication

  • 10.1. Valvular Heart Diseases
    • 10.1.1. Aortic Stenosis
    • 10.1.2. Mitral Regurgitation
    • 10.1.3. Pulmonary Valve Disease
  • 10.2. Cardiac Arrhythmias
    • 10.2.1. Bradycardia
    • 10.2.2. Tachycardia
    • 10.2.3. Atrial Fibrillation
  • 10.3. Heart Failure
  • 10.4. Cardiomyopathy

11. Cardiac Prosthetic Devices Market, by End User

  • 11.1. Ambulatory Surgical Centers
  • 11.2. Cardiac Centers
  • 11.3. Hospitals

12. Cardiac Prosthetic Devices Market, by Distribution Channel

  • 12.1. Online
  • 12.2. Offline

13. Cardiac Prosthetic Devices Market, by Region

  • 13.1. Asia-Pacific
  • 13.2. North America
  • 13.3. Latin America
  • 13.4. Europe
  • 13.5. Middle East
  • 13.6. Africa

14. Cardiac Prosthetic Devices Market, by Group

  • 14.1. ASEAN
  • 14.2. GCC
  • 14.3. European Union
  • 14.4. BRICS
  • 14.5. G7
  • 14.6. NATO

15. Cardiac Prosthetic Devices Market, by Country

  • 15.1. United States
  • 15.2. Canada
  • 15.3. Mexico
  • 15.4. Brazil
  • 15.5. United Kingdom
  • 15.6. Germany
  • 15.7. France
  • 15.8. Russia
  • 15.9. Italy
  • 15.10. Spain
  • 15.11. China
  • 15.12. India
  • 15.13. Japan
  • 15.14. Australia
  • 15.15. South Korea

16. Competitive Landscape

  • 16.1. Market Concentration Analysis, 2025
    • 16.1.1. Concentration Ratio (CR)
    • 16.1.2. Herfindahl Hirschman Index (HHI)
  • 16.2. Recent Developments & Impact Analysis, 2025
  • 16.3. Product Portfolio Analysis, 2025
  • 16.4. Benchmarking Analysis, 2025

17. Company Profiles

  • 17.1. 4C Medical Technologies, Inc.
  • 17.2. Abbott Laboratories
  • 17.3. Artivion, Inc.
  • 17.4. AtriCure, Inc.
  • 17.5. Berlin Heart GmbH
  • 17.6. BIOTRONIK SE & Co. KG
  • 17.7. Boston Scientific Corporation
  • 17.8. Braile Biomedica
  • 17.9. Colibri Heart Valve, LLC
  • 17.10. Corcym S.r.l.
  • 17.11. Edwards Lifesciences Corporation
  • 17.12. Getinge AB
  • 17.13. JenaValve Technology, Inc.
  • 17.14. Labcor Laboratorios Ltda.
  • 17.15. Lepu Medical Technology (Beijing) Co., Ltd.
  • 17.16. LivaNova PLC
  • 17.17. Medtronic plc
  • 17.18. Meril Life Sciences Pvt. Ltd.
  • 17.19. MicroPort Scientific Corporation
  • 17.20. Shree Pacetronix Ltd.
  • 17.21. SynCardia Systems, LLC
  • 17.22. Terumo Corporation
  • 17.23. TTK Healthcare Ltd.
  • 17.24. Venus Medtech (Hangzhou) Inc.
  • 17.25. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, YEARS CONSIDERED FOR THE STUDY
  • FIGURE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, RESEARCH DESIGN
  • FIGURE 3. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, RESEARCH FRAMEWORK
  • FIGURE 4. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, DATA TRIANGULATION
  • FIGURE 5. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • FIGURE 6. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SHARE, BY KEY PLAYER, 2025
  • FIGURE 7. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET, FPNV POSITIONING MATRIX, 2025
  • FIGURE 8. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
  • FIGURE 9. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 10. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2032 (%)
  • FIGURE 11. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 12. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2032 (%)
  • FIGURE 13. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 14. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2032 (%)
  • FIGURE 15. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 16. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2032 (%)
  • FIGURE 17. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 18. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
  • FIGURE 19. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 20. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2032 (%)
  • FIGURE 21. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 22. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
  • FIGURE 23. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
  • FIGURE 24. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
  • FIGURE 25. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)

LIST OF TABLES

  • TABLE 1. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 2. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 3. GLOBAL HEART VALVES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 4. GLOBAL HEART VALVES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 5. GLOBAL HEART VALVES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 6. GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 7. GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 8. GLOBAL LEFT VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 9. GLOBAL DURABLE VENTRICULAR ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 10. GLOBAL DURABLE VENTRICULAR ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 11. GLOBAL DURABLE VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 12. GLOBAL TEMPORARY VENTRICULAR ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 13. GLOBAL TEMPORARY VENTRICULAR ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 14. GLOBAL TEMPORARY VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 15. GLOBAL PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 16. GLOBAL PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 17. GLOBAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 18. GLOBAL IMPLANTABLE PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 19. GLOBAL IMPLANTABLE PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 20. GLOBAL IMPLANTABLE PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 21. GLOBAL SINGLE CHAMBER PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 22. GLOBAL SINGLE CHAMBER PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 23. GLOBAL SINGLE CHAMBER PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 24. GLOBAL DUAL CHAMBER PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 25. GLOBAL DUAL CHAMBER PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 26. GLOBAL DUAL CHAMBER PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 27. GLOBAL TRIPLE CHAMBER PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 28. GLOBAL TRIPLE CHAMBER PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 29. GLOBAL TRIPLE CHAMBER PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 30. GLOBAL EXTERNAL PACEMAKERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 31. GLOBAL EXTERNAL PACEMAKERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 32. GLOBAL EXTERNAL PACEMAKERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 33. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 34. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 35. GLOBAL IMPLANTABLE CARDIOVERTER DEFIBRILLATORS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 36. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 37. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 38. GLOBAL VENTRICULAR ASSIST DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 39. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 40. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 41. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 42. GLOBAL SURGICAL PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 43. GLOBAL OPEN HEART SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 44. GLOBAL OPEN HEART SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 45. GLOBAL OPEN HEART SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 46. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 47. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 48. GLOBAL MINIMALLY INVASIVE SURGERY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 49. GLOBAL TRANSCATHETER PROCEDURES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 50. GLOBAL TRANSCATHETER PROCEDURES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 51. GLOBAL TRANSCATHETER PROCEDURES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 52. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 53. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 54. GLOBAL TRANSCATHETER AORTIC VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 55. GLOBAL TRANSCATHETER MITRAL VALVE REPLACEMENT MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 56. GLOBAL TRANSCATHETER MITRAL VALVE REPLACEMENT MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 57. GLOBAL TRANSCATHETER MITRAL VALVE REPLACEMENT MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 58. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 59. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 60. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 61. GLOBAL BIOLOGICAL MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 62. GLOBAL BOVINE TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 63. GLOBAL BOVINE TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 64. GLOBAL BOVINE TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 65. GLOBAL PORCINE TISSUE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 66. GLOBAL PORCINE TISSUE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 67. GLOBAL PORCINE TISSUE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 68. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 69. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 70. GLOBAL SYNTHETIC MATERIALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 71. GLOBAL POLYMERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 72. GLOBAL POLYMERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 73. GLOBAL POLYMERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 74. GLOBAL PYROLYTIC CARBON MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 75. GLOBAL PYROLYTIC CARBON MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 76. GLOBAL PYROLYTIC CARBON MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 77. GLOBAL METALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 78. GLOBAL METALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 79. GLOBAL METALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 80. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 81. GLOBAL VALVULAR HEART DISEASES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 82. GLOBAL VALVULAR HEART DISEASES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 83. GLOBAL VALVULAR HEART DISEASES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 84. GLOBAL AORTIC STENOSIS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 85. GLOBAL AORTIC STENOSIS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 86. GLOBAL AORTIC STENOSIS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 87. GLOBAL MITRAL REGURGITATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 88. GLOBAL MITRAL REGURGITATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 89. GLOBAL MITRAL REGURGITATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 90. GLOBAL PULMONARY VALVE DISEASE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 91. GLOBAL PULMONARY VALVE DISEASE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 92. GLOBAL PULMONARY VALVE DISEASE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 93. GLOBAL CARDIAC ARRHYTHMIAS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 94. GLOBAL CARDIAC ARRHYTHMIAS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 95. GLOBAL CARDIAC ARRHYTHMIAS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 96. GLOBAL BRADYCARDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 97. GLOBAL BRADYCARDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 98. GLOBAL BRADYCARDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 99. GLOBAL TACHYCARDIA MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 100. GLOBAL TACHYCARDIA MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 101. GLOBAL TACHYCARDIA MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 102. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 103. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 104. GLOBAL ATRIAL FIBRILLATION MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 105. GLOBAL HEART FAILURE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 106. GLOBAL HEART FAILURE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 107. GLOBAL HEART FAILURE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 108. GLOBAL CARDIOMYOPATHY MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 109. GLOBAL CARDIOMYOPATHY MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 110. GLOBAL CARDIOMYOPATHY MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 111. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 112. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 113. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 114. GLOBAL AMBULATORY SURGICAL CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 115. GLOBAL CARDIAC CENTERS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 116. GLOBAL CARDIAC CENTERS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 117. GLOBAL CARDIAC CENTERS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 118. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 119. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 120. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 121. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 122. GLOBAL ONLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 123. GLOBAL ONLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 124. GLOBAL ONLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 125. GLOBAL OFFLINE MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 126. GLOBAL OFFLINE MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 127. GLOBAL OFFLINE MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 128. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
  • TABLE 129. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 130. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 131. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 132. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 133. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 134. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 135. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 136. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 137. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 138. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 139. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 140. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 141. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 142. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 143. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 144. ASIA-PACIFIC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 145. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 146. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 147. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 148. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 149. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 150. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 151. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 152. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 153. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 154. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 155. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 156. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 157. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 158. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 159. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 160. NORTH AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 161. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 162. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 163. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 164. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 165. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 166. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 167. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 168. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 169. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 170. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 171. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 172. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 173. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 174. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 175. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 176. LATIN AMERICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 177. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 178. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 179. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 180. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 181. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 182. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 183. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 184. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 185. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 186. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 187. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 188. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 189. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 190. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 191. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 192. EUROPE CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 193. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 194. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 195. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 196. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 197. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 198. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 199. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 200. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 201. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 202. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 203. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 204. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 205. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 206. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 207. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 208. MIDDLE EAST CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 209. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 210. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 211. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 212. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 213. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 214. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 215. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 216. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 217. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 218. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 219. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 220. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 221. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 222. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 223. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 224. AFRICA CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 225. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
  • TABLE 226. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 227. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 228. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 229. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 230. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 231. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 232. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 233. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 234. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 235. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 236. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 237. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 238. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 239. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 240. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 241. ASEAN CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 242. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 243. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 244. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 245. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 246. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 247. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 248. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 249. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 250. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 251. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 252. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 253. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 254. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 255. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 256. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 257. GCC CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 258. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 259. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 260. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 261. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 262. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 263. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 264. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 265. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 266. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 267. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 268. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 269. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 270. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 271. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 272. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 273. EUROPEAN UNION CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 274. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 275. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 276. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 277. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 278. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 279. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 280. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 281. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 282. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 283. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 284. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 285. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 286. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 287. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 288. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 289. BRICS CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 290. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 291. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 292. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 293. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 294. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 295. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 296. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 297. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 298. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 299. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 300. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 301. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 302. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 303. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 304. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 305. G7 CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 306. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 307. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 308. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 309. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 310. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 311. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 312. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 313. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 314. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 315. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 316. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 317. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 318. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY VALVULAR HEART DISEASES, 2018-2032 (USD MILLION)
  • TABLE 319. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY CARDIAC ARRHYTHMIAS, 2018-2032 (USD MILLION)
  • TABLE 320. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
  • TABLE 321. NATO CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2032 (USD MILLION)
  • TABLE 322. GLOBAL CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
  • TABLE 323. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, 2018-2032 (USD MILLION)
  • TABLE 324. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PRODUCT TYPE, 2018-2032 (USD MILLION)
  • TABLE 325. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY LEFT VENTRICULAR ASSIST DEVICES, 2018-2032 (USD MILLION)
  • TABLE 326. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 327. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY IMPLANTABLE PACEMAKERS, 2018-2032 (USD MILLION)
  • TABLE 328. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY PROCEDURE TYPE, 2018-2032 (USD MILLION)
  • TABLE 329. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SURGICAL PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 330. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY TRANSCATHETER PROCEDURES, 2018-2032 (USD MILLION)
  • TABLE 331. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY MATERIAL TYPE, 2018-2032 (USD MILLION)
  • TABLE 332. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY BIOLOGICAL MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 333. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY SYNTHETIC MATERIALS, 2018-2032 (USD MILLION)
  • TABLE 334. UNITED STATES CARDIAC PROSTHETIC DEVICES MARKET SIZE, BY INDICATION, 2018-2032 (USD MILLION)
  • TABLE 335. UN